Evaluation of the relationship between TNFα, sTNFR1, sTNFR2, sIL2R, IL6, neopterin with disease activity in ankylosing spondylitis
- 30 January 2018
- journal article
- research article
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 43 (5) , 487-494
Abstract
Objective: We aimed to evaluate the relationship among TNFα, sTNFR1, sTNFR2, sIL2R, IL6, neopterin and disease activity in ankylosing spondylitis (AS). Materials and methods: TNFα, sTNFR1, sTNFR2, sIL2R, IL6 and neopterin were measured in patients and controls. Patients were grouped according to disease activity and medication. Results: Neopterin and sTNFR1 were not different while TNFα, sTNFR2, sIL2R and IL6 were high in patients than controls. There was no difference between active and inactive patients for TNFα, sIL2R and IL6. sTNFR2 was significantly lower in active patients. There was no relationship between CRP positivity and disease activity. AS patient groups are; 1: TNF blockers, 2: nonsteroidal anti-inflammatory drugs (NSAIDs), 3: disease modifying anti-rheumatic drugs (DMARDs), 4: TNF blockers and NSAIDs, 5: DMARDs and NSAIDs. sTNFR2 was significantly lower in active patients than in inactive, in Group 1. ESR levels were significantly lower in inactive patients compared to active in group 3 and 4. There was no significant association between CRP positivity and disease activity. Conclusion: According to our study, CRP is insufficient in evaluating AS disease activity. ESR can be useful in evaluating the disease activity. sTNFR2 might be useful as a biological indicator of disease activity in AS treated with TNF inhibitors alone.Keywords
This publication has 31 references indexed in Scilit:
- Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritisArthritis Care & Research, 2010
- Developments in the scientific and clinical understanding of the spondyloarthritidesArthritis Research & Therapy, 2009
- The relationship between inflammation and new bone formation in patients with ankylosing spondylitisArthritis Research & Therapy, 2008
- TNF‐mediated inflammatory diseaseThe Journal of Pathology, 2007
- Diagnosis and management of ankylosing spondylitisBMJ, 2006
- Comparison of serum IL-1β, sIL-2R, IL-6, and TNF-α levels with disease activity parameters in ankylosing spondylitisClinical Rheumatology, 2006
- Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectivesRheumatology, 2005
- Spondyloarthropathies: using presentation to make the diagnosis.Cleveland Clinic Journal of Medicine, 2004
- Advances in interleukin 2 receptor targeted treatmentAnnals of the Rheumatic Diseases, 2000
- The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and deathCell, 1994